UMIN ID: UMIN000001558
Registered date:11/12/2008
Third-line H. pylori eradication therapy with sitafloxacin-including regimen
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Patients with H. pylori eradication failure after the second-line regimen |
| Date of first enrollment | 2008/12/01 |
| Target sample size | 30 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | H. pylori eradication therapy with sitafloxacin-including regimen |
Outcome(s)
| Primary Outcome | Eradication rate of H. pylori by sitafloxacin-including regimen |
|---|---|
| Secondary Outcome | MIC of sitafloxacin, gyrA mutation of H. pylori |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 90years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | penicillin or quinolone allergy rabeprazole allergy severe liver dysfunction, renal dysfunction pregnancy or possibly pregnancy cases with unsuitable recognition by doctors |
Related Information
| Primary Sponsor | DIvision of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Donation to the Department |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Hidekazu Suzuki |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan Japan |
| Telephone | 03-5363-3914 |
| hsuzuki@sc.itc.keio.ac.jp | |
| Affiliation | Keio University School of Medicine Division of Gastroenterology and Hepatology, Department of Internal Medicine |
| scientific contact | |
| Name | Hidekazu Suzuki, M.D., Ph.D. |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan Japan |
| Telephone | 03-5363-3914 |
| Affiliation | Keio University School of Medicine Division of Gastroenterology and Hepatology, Department of Internal Medicine |